Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04553549 · ClinicalTrials.gov registry record
Safety and Feasibility of the Infinity Catheter for Radial Access
A clinical trial of Brain Tumor and Stroke, Acute, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- 80
- Enrollment target
- 1
- Study location
NCT04553549 is a study of Brain Tumor and Stroke, Acute that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 80 participants, below the 280-participant average among 69 other Brain Tumor trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04553549, a study of Brain Tumor and Stroke, Acute, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The main objective of this single arm study is to evaluate the safety and feasibility of the AXS Infinity LS (Stryker, Freemont, CA, USA) and AXS Infinity LS Plus (Stryker, Freemont, CA, USA) catheters during the transradial approach through a secondary use of the data collected during neurointerventional procedures. This includes evaluating the conversion rates to a transfemoral approach. A secondary aim of the study is to assess the radial artery occlusion rates post procedure.
Conditions Studied
Interventions
- DEVICE Transradial approach
Study Locations (1)
New Jersey
- University Hospital - Newark
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2020-10-01 |
| Est. Completion | 2022-10-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04553549
The ClinicalTrials.gov registry entry for NCT04553549 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 280-participant average among 69 other Brain Tumor trials with a reported enrollment target (71% lower). The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Brain Tumor appearing as the primary indexed condition, and to 1 intervention - of which Transradial approach is the first listed.
NCT04553549 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT04553549 about?
NCT04553549 is a clinical study titled "Safety and Feasibility of the Infinity Catheter for Radial Access". The main objective of this single arm study is to evaluate the safety and feasibility of the AXS Infinity LS (Stryker, Freemont, CA, USA) and AXS Infinity LS Plus (Stryker, Freemont, CA, USA) catheters during the transradial approach through a secondary use of the data collected during neurointerven...
What is the current status of trial NCT04553549?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2020-10-01. Estimated completion is 2022-10-30.
What conditions does trial NCT04553549 study?
This clinical trial studies the following conditions: Brain Tumor, Stroke, Acute, Carotid Stenosis, Brain Aneurysm, Intracranial Arteriovenous Malformations.
What interventions are being tested in trial NCT04553549?
The interventions under investigation include: Transradial approach (DEVICE).
Who is sponsoring clinical trial NCT04553549?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04553549 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Tumor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
RECRUITING · Phase 1
-
A Comprehensive Clinical fMRI Software Solution to Enable Mapping of Critical Functional Networks and Cerebrovascular Reactivity in the Brain
RECRUITING
-
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
RECRUITING · Phase 1
-
LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)
RECRUITING · NA
-
Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.
RECRUITING · Phase 1
-
Brodalumab in the Treatment of Immune-Related Adverse Events
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.